The National Institutes of Health announced Monday it was enrolling hundreds of people in phase 2 clinical trials that will evaluate at least four potential treatments for long COVID.
The news underscores that the government recognizes the importance of developing treatment therapies to improve the lives of thousands of people who never completely recovered from the novel coronavirus, Northeastern researchers Kristin Kostka and Mauricio Santillana say.
Read more from Northeastern Global News
Europa Press via AP
